The therapeutic dilemma of immunosuppressive drugs for refractory cardiac sarcoidosis in COVID‐19 infection

Patients with refractory cardiac sarcoidosis (CS) take a high dose of corticosteroid and immunosuppressive agents. During the pandemic outbreak of severe acute respiratory syndrome coronavirus 2, appropriate treatment of corticosteroids or immunosuppressive agents in CS patients with coronavirus dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Kohsaku, Uehara, Masae, Okamoto, Koh, Takeda, Norifumi, Morita, Hiroyuki, Hatano, Masaru, Komuro, Issei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653200/
https://www.ncbi.nlm.nih.gov/pubmed/34697891
http://dx.doi.org/10.1002/ehf2.13676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653200/
https://www.ncbi.nlm.nih.gov/pubmed/34697891
http://dx.doi.org/10.1002/ehf2.13676

Ejemplares similares